Thomas Zeltner

Last updated
Thomas Zeltner
Born (1947-11-15) November 15, 1947 (age 72)
NationalitySwiss
OccupationPhysician, lawyer, and former Secretary of Health of Switzerland
Known forFormer Secretary of Health of Switzerland; co-founder of the Global Patient Safety Forum; Professor of Public Health at the University of Berne, Switzerland; Visiting Scientist at the Harvard School of Public Health; President of the Swiss Commission for UNESCO; and Board Member of the Medical University of Vienna

Thomas Zeltner (born 1947 in Berne, Switzerland) is a Swiss physician, lawyer, and former Secretary of Health of Switzerland Federal Department of Home Affairs FDHA. He has a long history as an innovative leader in public health and has repeatedly been ranked among the 12 most influential political figures of Switzerland. [1]

Contents

Zeltner is Professor at the University of Berne, Switzerland, in Public Health and Visiting Scientist at the Harvard School of Public Health. He chairs the Swiss Research Institute for Public Health and Addiction (Zürich) and is President of UNESCO Commission of Switzerland. He advises the Swiss government in the implementation and future development of The National Health Policy. He is also the Vice Chair of the University Council of the Medical University of Vienna.

Currently he is the project leader and designated first chairman of the WHO Foundation established in Geneva in 2020. The WHO Foundation is a lean, impact-driven grant-making organization with the objective of addressing the most pressing global health challenges of tomorrow by financing WHO and its partners implementing the SDGs and WHO's general program of work.

Along with J. Michael Henderson, he is a co-founder of the Global Patient Safety Forum, a collaborative forum for global healthcare leaders. He is President of KPT Health Insurance, Switzerland and of Swiss Transfusion SRC Inc.

Past

Zeltner was graduated with an M.D. and an LL.M. (master's in law) from the University of Berne. He specialized in human pathology and forensic medicine before becoming the head of Medical Services at the Bern University Hospital. He held various faculty positions at the University of Bern and at the Harvard School of Public Health. He is Doctor of law (honoris causa) of the University of Neuchâtel, Switzerland.

In 1991, the Swiss Government appointed Zeltner as the 8th Director-General of the Swiss National Health Authority and Secretary of Health of Switzerland, a position he held until the end of 2009.

Under Zeltner's leadership, Switzerland developed in 1991 a pioneering illicit drug policy, which has received global attention. It is based on a 4-pillar strategy (prevention, harm reduction, therapy, and law enforcement), which is enshrined in the Swiss law on narcotic drugs. The harm reduction policy of Switzerland – which includes large-scale syringe exchange programs (also in prisons) [2] and the medical prescription of heroin for chronic heroin addicts – was introduced against the strong opposition of the UN drug control authorities, [3] but endorsed by a majority of the Swiss population in several popular referenda. [4]

In 1999-2000, at the request of the then-Director General of WHO, Gro Harlem Brundtland, Zeltner chaired a committee which investigated the efforts of multinational tobacco companies to undermine tobacco control activities of the World Health Organization (2000). [5] This landmark report marks the beginning of the development of the WHO Framework Convention on Tobacco Control (2003). [6] With his efforts to reduce tobacco consumption in Switzerland, Zeltner became a favorite adversary of big tobacco and was nicknamed “the Tobacco Taliban." [7]

As Director General of the Swiss Federal Office of Public Health, he presided over changes to transform the regulated market model of the Swiss health care sector into a more value- and consumer-driven health care system. The Swiss model guarantees access to affordable insurance to all, even if they have pre-existing medical problems. All residents are required to buy insurance even if they are currently healthy, so that the risk pool remains reasonably favorable. Finally subsidies are given to low income families to pay for their premiums. Even though the Swiss pay 11.5% of the GDP for health (data 2015), [8] a majority of 78% considers that the system works well or very well. [9] The Swiss health care model is gaining increased international interest, particularly in the U.S. [10]

Zeltner was a member and Vice-President of the Executive Board of the World Health Organization (WHO) (1999-2002). He chaired the committee to reform the governance rules of the WHO in 2002-4. He was also Executive President of the WHO Regional Committee for Europe (1994–95) and Chairman of the Governing Council of the International Agency for Research on Cancer, (1998-2000). Between 2012 and 2014, Zeltner served the World Health Organization (WHO) in the capacity of a Special Envoy. [11] In this function he advised the Director General of WHO, Margaret Chan, in critical areas of the ongoing reform of this UN agency [12] [13] including how to cooperate with non-State actors [NGOs and the private sector] without compromising WHO's integrity; and how to better align WHO's priorities with the resources available to finance them. The work was successfully completed by adoption of the Framework of Engagement with Non-State Actors (FENSA) by the World Health Assembly in May 2016.

Current position

He serves as an advisor of the Swiss Government for the implementation of the National Health Policy, Health2020.

He is co-founder of the Global Patient Safety Forum, a convening organization of the world's leading patient safety organizations and member of the steering board of the Global Patient Safety Challenge, Medication Safety, of the World Health Organization. Other co-founders include J. Michael Henderson. He is a member of the editorial board of the journal Health Systems and Reform.

Since 1992, he has been Professor of Public Health at the University of Berne and is a Visiting Scientist at the Harvard School of Public Health (Boston). From 2018-22 he serves as a member of the Board of the Medical University of Vienna (Austria). Zeltner is Chairman of the board of the health insurer KPT, the leading online insurance company in Switzerland, which is repeatedly qualified as the best health insurer of Switzerland. [14] He is also president of Blood Transfusion CRS Switzerland, the organization in charge of securing Switzerland's provision with blood and blood products.

Related Research Articles

Health care reform is for the most part governmental policy that affects health care delivery in a given place. Health care reform typically attempts to:

World Health Organization Specialized agency of the United Nations

The World Health Organization (WHO) is a specialized agency of the United Nations that is concerned with international public health. It was established on 7 April 1948, and is headquartered in Geneva, Switzerland. The WHO is a member of the United Nations Development Group. Its predecessor, the Health Organization, was an agency of the League of Nations.

A health system, also sometimes referred to as health care system or as healthcare system, is the organization of people, institutions, and resources that deliver health care services to meet the health needs of target populations.

WHO Framework Convention on Tobacco Control

The World Health Organization Framework Convention on Tobacco Control is a treaty adopted by the 56th World Health Assembly held in Geneva, Switzerland on 21 May 2003. It became the first World Health Organization treaty adopted under article 19 of the WHO constitution. The treaty came into force on 27 February 2005. It had been signed by 168 countries and is legally binding in 181 ratifying countries. There are currently 15 United Nations member states that are non-parties to the treaty.

Julio Frenk Mexican politician

Julio José Frenk Mora is a Mexican physician and former secretary of Health of Mexico. Frenk is currently the president of the University of Miami. He is the University of Miami's first Hispanic and native Spanish-speaking president. Frenk formerly served as dean of the faculty and T & G Angelopoulos professor of public health and international development at the Harvard School of Public Health, from 2009 to 2015, where he had been the university's first Hispanic and native Spanish-speaking dean.

Drug policy reform, also known as drug law reform, is any proposed changes to the way governments respond to the socio-cultural influence on perception of psychoactive substance use. Proponents of drug policy reform believe that prohibition of drugs—such as cannabis, opioids, cocaine, amphetamines and hallucinogens—has been ineffectual and counterproductive. They argue that, rather than using laws and enforcement as the primary means to responding to substance use, governments and citizens would be better served by reducing harm and regulating the production, marketing, and distribution of currently illegal drugs in a manner similar to how alcohol and tobacco are regulated.

The Law Enforcement Action Partnership (LEAP), formerly Law Enforcement Against Prohibition, is a U.S.-based 501(c)(3) nonprofit group of current and former police, judges, prosecutors, and other criminal justice professionals who use their expertise to advance drug policy and criminal justice solutions that enhance public safety. The organization is modeled after Vietnam Veterans Against the War. As of April 2017, they have more than 180 representatives around the world who speak on behalf of over 5,000 law enforcement members and 100,000 supporters.

Health policy policy area, which deals with the planning, organization, management and financing of the health system

Health policy can be defined as the "decisions, plans, and actions that are undertaken to achieve specific healthcare goals within a society". According to the World Health Organization, an explicit health policy can achieve several things: it defines a vision for the future; it outlines priorities and the expected roles of different groups; and it builds consensus and informs people.

The Anti-Narcotics Force is a Federal Executive bureau of the Government of Pakistan, tasked with combating the narcotics smuggling and use within Pakistan. ANF works under umbrella of Pakistan Army and Ministry of Narcotics Control (Pakistan) of which Shehryar Khan Afridi is minister since 11 June 2019. Due to misconception on Section 4 of ANF ACT 1997, the force's head consisted the active-duty general officer of Pakistan Army. Although the law prescribes that any competent person may be appointed as Director General. Currently a two star Army Officer, Major general Arif Malik HI(M) is deputed as Director General. The ANF also has sole responsibility for co-ordinating and pursuing Pakistan narcotics investigations abroad.

Tobacco harm reduction (THR) is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. It is an example of the concept of harm reduction, a strategy for dealing with the abuse of other drugs. Tobacco smoking is widely acknowledged as a leading cause of illness and death, and reducing smoking is vital to public health.

The Framework Convention Alliance (FCA), also called the Framework Convention Alliance for Tobacco Control, is a confederation of nearly 500 organizations from more than 100 countries which banded together to support the negotiation, ratification and implementation of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC). The FCA was formed in 1999 when negotiations began in Geneva.

Health in Bhutan is one of the government's highest priorities in its scheme of development and modernization. Health and related issues are overseen by the Ministry of Health, itself represented on the executive Lhengye Zhungtshog (cabinet) by the Minister of Health. As a component of Gross National Happiness, affordable and accessible health care is central to the public policy of Bhutan.

Tobacco control field of public health addressing tobacco use

Tobacco control is a field of international public health science, policy and practice dedicated to addressing tobacco use and thereby reducing the morbidity and mortality it causes. Tobacco control is a priority area for the World Health Organization (WHO), through the Framework Convention on Tobacco Control. References to a tobacco control movement may have either positive or negative connotations.

K. Srinath Reddy Indian cardiologist

K. Srinath Reddy is the president of the Public Health Foundation of India and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).

Sameh El-Saharty Senior Health Policy Specialist in Research Studies/Research Methodology in the Middle East and North Africa Region, The World Bank. Research Studies/Research Methodology

Sameh El-Saharty is an Egyptian medical doctor and expert in international health, he works as Lead Health Specialist and Program Leader for Human Development at The World Bank in Washington, DC. He is responsible for health, nutrition and population as well as education, social protection and labor markets in the Gulf Cooperation Council countries. Dr. El-Saharty joined the Bank in 1998 and was the first Egyptian to work in the health, population, and nutrition sector at the Bank since its establishment. During this period, he was responsible for leading the health policy dialog and health strategy development for client countries as well as managing several programs and projects amounting to more than $3.05 billion in more than 25 countries in three world regions. He also held the position of Adjunct Assistant Professor of International Health at Georgetown University in Washington, D.C.

The Social Protection Floor (SPF) is the first level of social protection in a national social protection system. It is a basic set of social rights derived from human right treaties, including access to essential services and social transfers, in cash or in kind, to guarantee income security, food security, adequate nutrition and access to essential services.

Dr. Derek Yach is a South African analyst of international health care policy and the current founder and president of the Philip Morris International-funded Foundation for a Smoke-Free World. He is a former World Health Organization cabinet director and an advocate of health promotion, smoking cessation and tobacco harm reduction.

The R Street Institute is an American conservative and libertarian think tank headquartered in Washington, D.C. The Institute's stated mission is to "engage in policy research and outreach to promote free markets and limited, effective government." R Street was established in 2012 when its founders split from the Heartland Institute out of disagreement with Heartland's public denial of the scientific consensus on climate change. In addition to its Washington headquarters, R Street has branch offices in Tallahassee, Florida; Columbus, Ohio; Sacramento, CA; Boston, MA; and Round Rock, TX.

Miklós Szócska Hungarian politician

Miklós Szócska is a Hungarian medical doctor, academic and politician, former Minister of State for Health of Hungary, the Director of The Health Services Management Training Centre of the Semmelweis University and a nominated candidate by the Hungarian Government for the General-Director position of the WHO in 2016.

Society for Research on Nicotine and Tobacco other organization in Madison, United States

The Society for Research on Nicotine and Tobacco (SRNT) is an international organization that studies and shares research on nicotine and tobacco use from a public health and scientific perspective. It is the largest organization focused on nicotine and tobacco, with members in 40 countries. SRNT’s work has been used by the World Health Organization and governments in setting policies on topics such as tobacco advertising, taxation, smoke-free laws, and smoking cessation. SRNT has been particularly active in work on the WHO Framework Convention on Tobacco Control and the Tobacco Master Settlement Agreement in the US. SRNT is a nonprofit organization and publishes the scientific journal Nicotine and Tobacco Research. SRNT does not accept funding from the tobacco industry. The organization does accept funding from pharmaceutical companies that make medications to help people quit smoking.

References

  1. http://www.bilanz.ch/luxus/geballte-macht Die Mächtigsten: Geballte Macht
  2. "Nicole Pepper for the Harm Reduction Coalition. Syringe Exchange in Prisons: The International Experience". Harm Reduction Coalition. 2007. Retrieved 31 Jul 2013.
  3. "Report of the International Narcotics Control Board for 1995" (PDF). International Narcotics Control Board. 1996. Retrieved 31 Jul 2013.
  4. Savary JF, Hallam C, Bewley-Taylor D (2009). "The Swiss Four Pillars Policy: an evolution from local experimentation to federal law" (PDF). The Beckley Foundation Drug Policy Programme. Briefing Paper Eighteen.
  5. Zeltner T, Kessler DA, Martiny A, Randera F (Jul 2000). "Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization. Report of the Committee of Experts on Tobacco Industry Documents" (PDF). Geneva, Switzerland. Retrieved 2 August 2013.
  6. Reynolds LA, Tansey EM, eds. (2010) The transcript of a Witness Seminar organized by the Wellcome Trust Centre for the History of Medicine at UCL, in collaboration with the Department of Knowledge Management and Sharing, WHO, held in Geneva, on 26 February 2010. WHO Framework Convention on Tobacco Control. Retrieved 31 Jul 2013.
  7. Ullekh NP (Jun 2, 2013). "Tobacco industry's bet on India & China may lead to surge in lifestyle diseases: Thomas Zeltner". The Economic Times (India).
  8. "Swiss Federal Statistical Office: Costs, financing". Swiss Federal Administration. 2013. Retrieved 1 August 2013.
  9. "Trend zu mehr Eigenverantwortung und weniger Solidarität". Interpharma. 2013. Retrieved 1 August 2013.
  10. Cheng T-M (2010). "Understanding the 'Swiss watch' function of Switzerland's health system". Health Aff (Millwood). 29 (8): 1442–51. doi:10.1377/hlthaff.2010.0698. PMID   20707011.
  11. Cassels A. (Apr 2013). "Change @ WHO: New approach to financing". World Health Organization. Retrieved 1 August 2013.
  12. "WHO needs change". Nature Publishing Group. 12 May 2011. Retrieved 30 July 2013.
  13. "WHO reform process: Landmark events of the WHO reform process from the initial consultation on the future of financing for WHO". World Health Organization. Retrieved 30 July 2013.
  14. "Die KPT ist erneut Spitze im Service" (in German). Konsumenteninfo AG. 19 Sep 2012. Retrieved 1 August 2013.